Akebia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
CEOJohn P. Butler
CEOJohn P. Butler
Employees181
Employees181
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees181
Employees181
AKBA Key Statistics
Market cap780.85M
Market cap780.85M
Price-Earnings ratio-17.25
Price-Earnings ratio-17.25
Dividend yield—
Dividend yield—
Average volume3.96M
Average volume3.96M
High today$3.00
High today$3.00
Low today$2.91
Low today$2.91
Open price$2.99
Open price$2.99
Volume2.24M
Volume2.24M
52 Week high$4.08
52 Week high$4.08
52 Week low$1.24
52 Week low$1.24
AKBA News
Simply Wall St 1d
Retail investors who have a significant stake must be disappointed along with institutions after Akebia Therapeutics, Inc.'s market cap dropped by US$50mAdvertisement Key Insights The considerable ownership by retail investors in Akebia Therapeutics indicates that they collectively have a greater say in manage...
People also own
Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.